Adamu Uzairu Selected Research

Neoplasms (Cancer)

10/2023	Virtual screening, pharmacokinetic, and DFT studies of anticancer compounds as potential V600E-BRAF kinase inhibitors.
10/2023	New flavone-based arylamides as potential V600E-BRAF inhibitors: Molecular docking, DFT, and pharmacokinetic properties.
2/2023	In silico analysis of noscapine compounds as anti-tumor agents targeting the tubulin receptor.
1/2023	Modelling PIP4K2A inhibitory activity of 1,7-naphthyridine analogues using machine learning and molecular docking studies.
1/2022	Theoretical modeling and design of some pyrazolopyrimidine derivatives as Wolbachia inhibitors, targeting lymphatic filariasis and onchocerciasis.
4/2020	Computational studies of a series of 2-substituted phenyl-2-oxo-, 2-hydroxyl- and 2-acylloxyethylsulfonamides as potent anti-fungal agents.
3/2020	QSAR modelling and molecular docking studies for anti-cancer compounds against melanoma cell line SK-MEL-2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adamu Uzairu Research Topics

Disease

7	Neoplasms (Cancer) 10/2023 - 03/2020
5	Human Influenza (Influenza) 08/2023 - 01/2022
3	Melanoma (Melanoma, Malignant) 10/2023 - 03/2020
2	Schistosomiasis (Bilharziasis) 04/2024 - 01/2024
2	Leishmaniasis 11/2023 - 01/2023
2	Breast Neoplasms (Breast Cancer) 08/2023 - 12/2020
2	Mental Disorders (Mental Disorder) 07/2020 - 10/2019
1	Malaria 04/2024
1	Type 2 Diabetes Mellitus (MODY) 01/2024
1	Visceral Leishmaniasis (Kala Azar) 11/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2023
1	Rheumatoid Arthritis 01/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Chronic Disease (Chronic Diseases) 01/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023
1	COVID-19 12/2022
1	Schizophrenia (Dementia Praecox) 07/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Psychotic Disorders (Schizoaffective Disorder) 10/2019
1	Tuberculosis (Tuberculoses) 01/2018
1	Epilepsy (Aura) 01/2017

Drug/Important Bio-Agent (IBA)

4	Neuraminidase (Sialidase)IBA 08/2023 - 01/2022
3	VaccinesIBA 04/2024 - 01/2023
3	LigandsIBA 04/2024 - 07/2020
3	EnzymesIBA 01/2024 - 12/2022
2	Praziquantel (Biltricide)FDA Link 04/2024 - 01/2024
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2020
1	Peptide Elongation Factor 2 (EF-2)IBA 04/2024
1	7-keto-sempervirolIBA 01/2024
1	Oxamniquine FDA Link 01/2024
1	Amylases FDA Link 01/2024
1	Organoselenium CompoundsIBA 11/2023
1	Protein Kinases (Protein Kinase)IBA 10/2023
1	Phosphotransferases (Kinase)IBA 10/2023
1	Hemagglutinins (Hemagglutinin)IBA 05/2023
1	Noscapine (Narcotine)IBA 02/2023
1	TubulinIBA 02/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	Protein Tyrosine PhosphatasesIBA 01/2023
1	SARS-CoV-2 3C-like proteinaseIBA 01/2023
1	cyclohexanoneIBA 01/2023
1	Protein Isoforms (Isoforms)IBA 01/2023
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 12/2022
1	Peptide Hydrolases (Proteases)FDA Link 12/2022
1	Transcription Factors (Transcription Factor)IBA 12/2022
1	Deubiquitinating EnzymesIBA 01/2022
1	Doxycycline (Periostat)FDA LinkGeneric 01/2022
1	Estrogens (Estrogen)FDA Link 12/2020
1	Antipsychotic Agents (Antipsychotics)IBA 07/2020
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 07/2020
1	SulfonamidesIBA 04/2020
1	QuinazolinesIBA 02/2020
1	PiperazineIBA 01/2020
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 10/2019
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 10/2019
1	CytochromesIBA 01/2018
1	cytochrome P-450 CYP121IBA 01/2018
1	Vigabatrin FDA Link 01/2017

Therapy/Procedure

4	Therapeutics 11/2023 - 01/2022